The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells
Open accessAbstract
Glutamine is an essential nutrient that regulates energy production, redox homeostasis, and signaling in cancer cells. Despite the importance of glutamine in mitochondrial metabolism, the mitochondrial glutamine transporter has long been unknown. Here, we show that the SLC1A5 variant plays a critical role in cancer metabolic reprogramming by transporting glutamine into mitochondria. The SLC1A5 variant has an N-terminal targeting signal for mitochondrial localization. Hypoxia-induced gene expression of the SLC1A5 variant is mediated by HIF-2α. Overexpression of the SLC1A5 variant mediates glutamine-induced ATP production and glutathione synthesis and confers gemcitabine resistance to pancreatic cancer cells. SLC1A5 variant knockdown and overexpression alter cancer cell and tumor growth, supporting an oncogenic role. This work demonstrates that the SLC1A5 variant is a mitochondrial glutamine transporter for cancer metabolic reprogramming.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For mitochondrial glutaminolysis, cytosolic glutamine must be transported through the inner mitochondrial membrane via the SLC1A5 variant, a mitochondrial glutamine transporter16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“the mitochondrial glutamine transporter, encoded by a transcript variant of the SLC1A5 gene, which encodes a well-known plasma membrane glutamine transporter, was only recently discovered16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Although glutamate is the major downstream product of glutamine, glutamate supplementation during glutamine deprivation cannot rescue the impaired cell growth or mitochondrial respiration16,43–45, indicating that mitochondrial GLS-catalyzed cleavage of the gamma-nitrogen of glutamine is essential for glutaminolysis.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Hypoxic conditions promote the uptake of glutamine by increasing the levels of glutamine transporters such as SLC1A5, the SLC1A5 variant, and SLC38A216,65”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“and the mitochondrial glutamine transporter is strongly associated with glutaminolysis-induced NADPH generation16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Furthermore, redox modulation augmented by increased glutathione synthesis from glutamine was reported to be the mechanism of resistance to gemcitabine in pancreatic cancer cells16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Impairing glutamine metabolism also induces sensitivity in gemcitabine-resistant pancreatic cancer cells16,84,85.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Indeed, experiments using uniformly labeled 13C-glutamine showed that glutathione was enriched with five 13C atoms in glutathione, suggesting that glutamine is the major source of glutathione16,57,60.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Recently, hypoxia-induced expression of the SLC1A5 variant was shown to be mediated by HIF-2α and to lead to metabolic reprogramming toward glutamine metabolism in pancreatic cancer cells16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Intriguingly, this study regarding elevated glutamine metabolism in cancer cells also showed that glutaminolysis could in turn reinforce metabolic reprogramming, thus implying that glutamine metabolism plays a crucial role in tumorigenesis and tumor progression16”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Additionally, the level of the mitochondrial glutamine transporter controls the cellular ATP level stimulated by glutamine, suggesting that glutamine is an important energy source via mitochondrial glutaminolysis16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“in addition, the expression of the SLC1A5 variant affected the levels of metabolites derived from glucose metabolism, including lactate and ribulose-5-phosphate, the intermediate metabolites in the PPP16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Recently, glutamine was shown to be a major fuel for mitochondrial oxygen consumption in pancreatic cancer cells”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Thus, as the SLC1A5 variant is the only currently known glutamine transporter in the mitochondrial inner membrane16”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Given the clinicopathological significance of SLC1A5201 and the observation that the level of the SLC1A5 variant is negatively correlated with prognosis in several cancer types16”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“Conversely, suppression of the SLC1A5 variant, a mitochondrial glutamine transporter, is sufficient to inhibit tumor growth by impairing glutamine metabolism in pancreatic cancer cells16.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [16]
In the citing paper
“HIF‐2α‐induced expression of the glutamine transporter solute carrier family 1, member 5 (SLC1A5) mediates glutamine‐induced ATP production and glutathione synthesis and renders pancreatic cancer resistant to gemcitabine.”
From Hypoxia signaling in cancer: Implications for therapeutic interventions (2023) · cites this paper as [56]
Citations
Cites
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Intracellular Functions of N-Linked Glycans
Helenius, A., & Aebi, A. M. (2001) · Science · doi:10.1126/science.291.5512.2364 · Cited by 2,405
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., Yang, H., Hild, M., Kung, C., Wilson, C., et al. (2009) · Cell · doi:10.1016/j.cell.2008.11.044 · Cited by 1,798
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Glutamine addiction: a new therapeutic target in cancer
Wise, D. R., & Thompson, C. B. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.003 · Cited by 1,770
Semenza, G. L., Jiang, B.-H., Leung, S. W., Passantino, R., Concordet, J.-P., Maire, P., & Giallongo, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32529 · Cited by 1,752
Importing Mitochondrial Proteins: Machineries and Mechanisms
Chacińska, A., Koehler, C. M., Milenkovic, D., Lithgow, T. J., & Pfanner, N. (2009) · Cell · doi:10.1016/j.cell.2009.08.005 · Cited by 1,528
Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells
Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Zhang, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.009 · Cited by 1,095
Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells
Wieckowski, M. R., Giorgi, C., Lebiedzinska, M., Duszynski, J., & Pinton, P. (2009) · Nature Protocols · doi:10.1038/nprot.2009.151 · Cited by 979
Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1
Wang, S., Tsun, Z.-Y., Wolfson, R. L., Shen, K., Wyant, G. A., Plovanich, M., Yuan, E. D., Jones, T. D., Chantranupong, L., Comb, W. C., et al. (2015) · Science · doi:10.1126/science.1257132 · Cited by 865
Glutaminolysis: A Hallmark of Cancer Metabolism
Yang, L., Venneti, S., & Nagrath, D. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044546 · Cited by 859
Tkacz, J. S., & Lampen, J. O. (1975) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(75)80086-6 · Cited by 849
Glutaminolysis Activates Rag-mTORC1 Signaling
Durán, R. V., Oppliger, W., Robitaille, A. M., Heiserich, L., Skendaj, R., Gottlieb, E., & Hall, M. N. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.05.043 · Cited by 766
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761
Role of Bax and Bak in mitochondrial morphogenesis
Karbowski, M., Norris, K. L., Cleland, M. M., Jeong, S.-Y., & Youle, R. J. (2006) · Nature · doi:10.1038/nature05111 · Cited by 625
Shukla, S. K., Purohit, V., Mehla, K., Gunda, V., Chaika, N. V., Vernucci, E., King, R. J., Abrego, J., Goode, G. D., Dasgupta, A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.004 · Cited by 548
Self-citationAbsolute quantification of matrix metabolites reveals the dynamics of mitochondrial metabolism
Chen, W. W., Freinkman, E., Wang, T., Birsoy, K., & Sabatini, D. M. (2016) · Cell · doi:10.1016/j.cell.2016.07.040 · Cited by 500
Schulte, M. L., Fu, A., Zhao, P., Li, J., Geng, L., Smith, S. T., Kondo, J., Coffey, R. J., Johnson, M. O., Rathmell, J. C., et al. (2018) · Nature Medicine · doi:10.1038/nm.4464 · Cited by 494
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Cho, H., Du, X., Rizzi, J. P., Liberzon, E., Chakraborty, A. A., Gao, W., Carvo, I., Signoretti, S., Bruick, R. K., Josey, J. A., et al. (2016) · Nature · doi:10.1038/nature19795 · Cited by 451
Fan, J., Kamphorst, J. J., Mathew, R., Chung, M. K., White, E., Shlomi, T., & Rabinowitz, J. D. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.65 · Cited by 428
Wu, S., Zhou, F., Zhang, Z., & Xing, D. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08010.x · Cited by 423
SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival
Hassanein, M., Hoeksema, M. D., Shiota, M., Qian, J., Harris, B. K., Chen, H., Clark, J. E., Alborn, W. E., Eisenberg, R., & Massion, P. P. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2334 · Cited by 355
Hovius, R., Lambrechts, H. A. J., Nicolay, K., & KRUIJFF, B. D. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90036-n · Cited by 353
As Extracellular Glutamine Levels Decline, Asparagine Becomes an Essential Amino Acid
Pavlova, N. N., Hui, S., Ghergurovich, J. M., Fan, J., Intlekofer, A. M., White, R. M., Rabinowitz, J. D., Thompson, C. B., & Zhang, J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.006 · Cited by 341
Immortal Human Pancreatic Duct Epithelial Cell Lines with Near Normal Genotype and Phenotype
Ouyang, H., Mou, L.-J., Luk, C. K., Liu, N., Karásková, J., Squire, J. A., & Tsao, M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64800-6 · Cited by 317
Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens
Liu, X., Krawczyk, E., Suprynowicz, F. A., Palechor-Ceron, N., Yuan, H., Dakic, A., Simić, V., Zheng, Y., Sripadhan, P., Chen, C., et al. (2017) · Nature Protocols · doi:10.1038/nprot.2016.174 · Cited by 305
Willems, L., Jacque, N., Jacquel, A., Neveux, N., Maciel, T. T., Lambert, M., Schmitt, A., Poulain, L., Green, A. S., Uzunov, M., et al. (2013) · Blood · doi:10.1182/blood-2013-03-493163 · Cited by 295
Cassago, A., Ferreira, A. P. S., Ferreira, I. M., Fornezari, C., Gomes, E. R. M., Greene, K. S., Pereira, H. M., Garratt, R. C., Dias, S. M. G., & Ambrosio, A. L. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112495109 · Cited by 291
Davidson, J. D., Ma, L., Flagella, M., Geeganage, S., Gelbert, L. M., & Slapak, C. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3363 · Cited by 279
Kekuda, R., Prasad, P. D., Fei, Y.-J., Torres, V. I., Sinha, S., Yang‐Feng, T. L., Leibach, F. H., & Ganapathy, V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18657 · Cited by 270
Pochini, L., Scalise, M., Galluccio, M., & Indiveri, C. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00061 · Cited by 264
Hu, Y., Suárez, J., Fricovsky, E. S., Wang, H., Scott, B. T., Trauger, S. A., Han, W., Hu, Y., Oyeleye, M. O., & DILLMANN, W. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808518200 · Cited by 258
Evaluation of methods for measuring cellular glutathione content using flow cytometry
Hedley, D. W., & Chow, S. (1994) · Cytometry · doi:10.1002/cyto.990150411 · Cited by 245
Li, B., Cao, Y., Meng, G., Qian, L., Xu, T., Yan, C., Luo, O., Wang, S., Wei, J., Ding, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.063 · Cited by 245
Mitochondrial outer membrane contains a protein producing nonspecific diffusion channels.
Zalman, L. S., Nikaido, H., & Kagawa, Y. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85942-2 · Cited by 220
Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine
Yokoi, K., & Fidler, I. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0488 · Cited by 202
The role of ASCT2 in cancer: A review
Liu, Y., Zhao, T., Li, Z., Wang, L., Yuan, S., & Sun, L. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.007 · Cited by 162
Glutamine homeostasis and mitochondrial dynamics
Matés, J. M., Segura, J. A., Campos-Sandoval, J. A., Lobo, C., Alonso, L., Alonso, F. J., & Márquez, J. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.003 · Cited by 157
Sappington, D. R., Siegel, E. R., Hiatt, G., Desai, A., Penney, R. B., Jamshidi-Parsian, A., Griffin, R. J., & Boysen, G. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.01.021 · Cited by 143
Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets
Bröer, A., Fairweather, S., & Bröer, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00785 · Cited by 124
Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer
Lukey, M. J., Cluntun, A. A., Katt, W. P., Lin, M.-C. J., Druso, J. E., Ramachandran, S., Erickson, J. W., Le, H. H., Wang, Z.-E., Blank, B., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.076 · Cited by 103
Bröer, A., Gauthier-Coles, G., Rahimi, F., van Geldermalsen, M., Dorsch, D., Wegener, A. A., Holst, J., & Bröer, S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006378 · Cited by 101
Shukla, S. K., Purohit, V., Mehla, K., Gunda, V., Chaika, N. V., Vernucci, E., King, R. J., Abrego, J., Goode, G. D., Dasgupta, A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.08.008 · Cited by 98
Self-citationKung, L. A., Tao, S., Qian, J. X., Smith, M. G., Snyder, M. P., & Zhu, H. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.64 · Cited by 94
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
Chen, R., Lai, L. A., Sullivan, Y., Wong, M., Wang, L., Riddell, J., Jung, L., Pillarisetty, V. G., Brentnall, T. A., & Pan, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-08436-6 · Cited by 92
GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation
Velletri, T., Romeo, F., Tucci, P., Peschiaroli, A., Annicchiarico‐Petruzzelli, M., Niklison-Chirou, M. V., Amelio, I., Knight, R. A., Mak, T. W., Melino, G., et al. (2013) · Cell Cycle · doi:10.4161/cc.26771 · Cited by 87
Schulte, M. I., Khodadadi, A. B., Cuthbertson, M. L., Smith, J. A., & Manning, H. C. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.12.031 · Cited by 62
Indiveri, C., ABRUZZO, G., Stipani, I., & Palmieri, F. (1998) · Biochemical Journal · doi:10.1042/bj3330285 · Cited by 56
Multiple proteins with essential mitochondrial functions have glycosylated isoforms
Burnham‐Marusich, A. R., & Berninsone, P. M. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.04.004 · Cited by 53
Bothwell, P. J., Kron, C., Wittke, E., Czerniak, B. N., & Bode, B. P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072093 · Cited by 49
Glutamine transport by vesicles isolated from tumour-cell mitochondrial inner membrane
Molina, M., Segura, J. A., Aledo, J. C., Medina, M. Á., de Castro, I. N., & Márquez, J. (1995) · Biochemical Journal · doi:10.1042/bj3080629 · Cited by 31
Cited by
Sorted by citations
The role of ROS in tumour development and progression
Cheung, E. C., & Vousden, K. H. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-021-00435-0 · Cited by 1,663
Glutamine reliance in cell metabolism
Yoo, H. C., Yu, Y. C., Sung, Y., & Han, J. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00504-8 · Cited by 1,021
Self-citationMitochondrial signal transduction
Picard, M. A., & Shirihai, O. S. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.10.008 · Cited by 688
Metabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Heiden, M. G. V., & Locasale, J. W. (2021) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 675
Targeting glutamine metabolism as a therapeutic strategy for cancer
Jin, J., Byun, J., Choi, Y., & Park, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00971-9 · Cited by 605
Metadata
- Authors
- Yoo, H. C., Park, S. J., Nam, M., Kang, J., Kim, K., Yeo, J. H., Kim, J.-K., Heo, Y., Lee, H. S., Lee, M. Y., Lee, C. W., Kang, J. S., Kim, Y.-H., Lee, J., Choi, J., Hwang, G.-S., Bang, S., & Han, J. M.
- Affiliations
- Yonsei University (KR)
- Korea Basic Science Institute (KR)
- National Cancer Center (KR)
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Corresponding author
- Han, Jung Min
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 31
- Issue
- 2
- Pages
- 267-283.e12
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2995576736
- Cited by
- 449
- References
- 54
- Citations by year
- 2026: 65 · 2025: 78 · 2024: 87 · 2023: 67 · 2022: 67 · 2021: 55 · 2020: 29
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- KRIBB Repository (submittedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Funders
- National Research Foundation of Korea
- Korea Basic Science Institute
- Ministry of Education (2018R1A6A1A03023718)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- glutamine transport, tumor metabolic reprogramming, mitochondrial targeting signal, HIF-2α, hypoxia, glutathione synthesis, ATP production, gemcitabine resistance, pancreatic cancer, tumor growth
- MeSH terms
- Tumor Hypoxia, Endothelial PAS Domain-Containing Protein 1, Animals, Female, Glutamine, Humans, Mice, Inbred BALB C, Mitochondria, Neoplasms, Minor Histocompatibility Antigens, Amino Acid Transport System ASC, Cell Line, Tumor, Mice, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
